For the quarter ending 2025-09-30, XRAY made $904M in revenue. -$427M in net income. Net profit margin of -47.23%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net sales | 904 | 936 | 879 | 905 |
| Cost of products sold | 463 | 446 | 413 | 459 |
| Gross profit | 441 | 490 | 466 | 446 |
| Selling, general, and administrative expenses | 355 | 342 | 358 | 401 |
| Research and development expenses | 37 | 37 | 36 | 42 |
| Intangible asset impairments | - | - | 0 | - |
| Goodwill and intangible asset impairments | 262 | 235 | - | 170 |
| Restructuring and other costs | 5 | 4 | 9 | 8 |
| Operating loss | -218 | -128 | 63 | -509 |
| Interest expense, net | 23 | 24 | 19 | 17 |
| Other income | 11 | -1 | 0 | 2 |
| Loss before income taxes | -230 | -153 | 44 | -523 |
| Provision for income taxes | 198 | -109 | 25 | -95 |
| Net loss | -428 | -44 | 19 | -428 |
| Less net loss attributable to noncontrolling interest | -1 | 1 | -1 | 2 |
| Net loss attributable to dentsply sirona | -427 | -45 | 20 | -430 |
| Basic (in dollars per share) | -2.14 | -0.22 | 0.1 | -2.09 |
| Basic (in shares) | 199,500,000 | 199,300,000 | 199,100,000 | -410,800,000 |
| Diluted (in dollars per share) | -2.14 | -0.22 | 0.1 | -2.09 |
| Diluted (in shares) | 199,500,000 | 199,300,000 | 199,800,000 | -411,900,000 |
DENTSPLY SIRONA Inc. (XRAY)
DENTSPLY SIRONA Inc. (XRAY)